245 related articles for article (PubMed ID: 11005706)
1. Risk classification systems for drug use during pregnancy: are they a reliable source of information?
Addis A; Sharabi S; Bonati M
Drug Saf; 2000 Sep; 23(3):245-53. PubMed ID: 11005706
[TBL] [Abstract][Full Text] [Related]
2. Drugs during pregnancy: an issue of risk classification and information to prescribers.
Sannerstedt R; Lundborg P; Danielsson BR; Kihlström I; Alván G; Prame B; Ridley E
Drug Saf; 1996 Feb; 14(2):69-77. PubMed ID: 8852521
[TBL] [Abstract][Full Text] [Related]
3. Drug use during pregnancy and breast-feeding. A classification system for drug information.
Berglund F; Flodh H; Lundborg P; Prame B; Sannerstedt R
Acta Obstet Gynecol Scand Suppl; 1984; 126():1-55. PubMed ID: 6393685
[TBL] [Abstract][Full Text] [Related]
4. Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs.
Uhl K; Kennedy DL; Kweder SL
Drug Saf; 2002; 25(12):885-92. PubMed ID: 12241129
[TBL] [Abstract][Full Text] [Related]
5. Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugs.
Friedman JM
Teratology; 1993 Jul; 48(1):5-6. PubMed ID: 8102499
[No Abstract] [Full Text] [Related]
6. Prescription of hazardous drugs during pregnancy.
Malm H; Martikainen J; Klaukka T; Neuvonen PJ
Drug Saf; 2004; 27(12):899-908. PubMed ID: 15366977
[TBL] [Abstract][Full Text] [Related]
7. Evolving knowledge of the teratogenicity of medications in human pregnancy.
Adam MP; Polifka JE; Friedman JM
Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):175-82. PubMed ID: 21766440
[TBL] [Abstract][Full Text] [Related]
8. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy.
Murase JE; Heller MM; Butler DC
J Am Acad Dermatol; 2014 Mar; 70(3):401.e1-14; quiz 415. PubMed ID: 24528911
[TBL] [Abstract][Full Text] [Related]
9. FDA classification of drugs for teratogenic risk. Teratology Society Public Affairs Committee.
Teratology; 1994 Jun; 49(6):446-7. PubMed ID: 7747265
[TBL] [Abstract][Full Text] [Related]
10. Drug safety: Pregnancy rating classifications and controversies.
Wilmer E; Chai S; Kroumpouzos G
Clin Dermatol; 2016; 34(3):401-9. PubMed ID: 27265079
[TBL] [Abstract][Full Text] [Related]
11. Teratogenicity of recently introduced medications in human pregnancy.
Lo WY; Friedman JM
Obstet Gynecol; 2002 Sep; 100(3):465-73. PubMed ID: 12220765
[TBL] [Abstract][Full Text] [Related]
12. Potential human teratogenicity of frequently prescribed drugs.
Friedman JM; Little BB; Brent RL; Cordero JF; Hanson JW; Shepard TH
Obstet Gynecol; 1990 Apr; 75(4):594-9. PubMed ID: 2314777
[TBL] [Abstract][Full Text] [Related]
13. Obstetric toxicology: teratogens.
Levine M; O'Connor AD
Emerg Med Clin North Am; 2012 Nov; 30(4):977-90. PubMed ID: 23137407
[TBL] [Abstract][Full Text] [Related]
14. Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study.
Zomerdijk IM; Ruiter R; Houweling LM; Herings RM; Straus SM; Stricker BH
BJOG; 2015 Jul; 122(8):1119-29. PubMed ID: 25316196
[TBL] [Abstract][Full Text] [Related]
15. Caution advised in interpretation of US FDA risk classification for dermatological medications during pregnancy.
Wong JW; Heller MM; Murase JE
Dermatol Online J; 2012 Oct; 18(10):15. PubMed ID: 23122022
[TBL] [Abstract][Full Text] [Related]
16. FDA pregnancy risk categories and the CPS: do they help or are they a hindrance?
Law R; Bozzo P; Koren G; Einarson A
Can Fam Physician; 2010 Mar; 56(3):239-41. PubMed ID: 20228306
[TBL] [Abstract][Full Text] [Related]
17. Classification of drugs for teratogenic risk: an anachronistic way of counseling.
Merlob P; Stahl B
Teratology; 2002 Aug; 66(2):61-2. PubMed ID: 12210007
[No Abstract] [Full Text] [Related]
18. Classification of drugs for teratogenic risk.
Alván G; Danielsson BR; Kihlström I; Lundborg P; Prame B; Ridley E; Sannerstedt R
Eur J Clin Pharmacol; 1995; 48(3-4):177-8. PubMed ID: 7589037
[No Abstract] [Full Text] [Related]
19. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
Brucker MC; King TL
J Midwifery Womens Health; 2017 May; 62(3):308-316. PubMed ID: 28556499
[TBL] [Abstract][Full Text] [Related]
20. [Drugs during pregnancy and breastfeeding: new risk categories--antibiotics as a model].
Bertsche T; Haas M; Oberwittler H; Haefeli WE; Walter-Sack I
Dtsch Med Wochenschr; 2006 May; 131(18):1016-22. PubMed ID: 16673226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
